FDA Expands The Emergency Use Authorization Of Pfizer Booster

It’s been just revealed that the Food and Drug Administration on Monday expanded the Emergency Use Authorization of a booster dose of the Pfizer-BioNTech coronavirus vaccine to include youths 12 to 15.

Booster dose authorization is expanded 

The USA Today notes that the booster dose is the same strength as the dose approved in the primary series.

A booster dose was previously authorized by the FDA for emergency use for those 16 years of age and older.

“Today’s decision by the FDA to further expand the Emergency Use Authorization of a booster dose of our vaccine is critical to help us ultimately defeat this pandemic.”

This is what Pfizer CEO Albert Bourla said.

He continued and revealed the following:

“Broad use of boosters is essential to preserving a high level of protection against this disease and reducing the rate of hospitalizations.”

The same online publication notes that the Centers for Disease and Control and Prevention still must sign off on the authorization. Dr. Rochelle Walensky, the CDC director, is expected to make the final decision this week.

Making a new covid 19 vaccine 

In other news, it’s been revealed by the online publication Japan Times that experts in Tokyo are developing a “dream” covid 19 vaccine that offers lifetime efficacy.

This massive move is made in what would be a game-changer as the fight against the coronavirus continues. 

As you definitely know by now, we’re living in a time when it seems that most of the covid vaccines will require periodic boosters due to a decline in recipients’ antibody levels.

This means that the creation of a vaccine with lifetime efficacy could lead to huge financial savings globally.

As the same online publication notes, this would also give the world an upper hand against the coronavirus, which has infected more than 270 million people and claimed more than 5 million lives around the world.